ΝΙΚΟΛΟΠΟΥΛΟΥ ΛΕΥΚΗ

Κατηγορία: ΚΑΡΔΙΟΛΟΓΟΣ

Ειδική Καρδιολόγος

210 650 2100

προφιλ

Επιμελήτρια της Ε' Καρδιολογικής Κλινικής του Metropolitan General
Διδάκτωρ Ιατρικής Σχολής Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών

ΕΚΠΑΙΔΕΥΣΗ & ΑΚΑΔΗΜΑΪΚΟΙ ΤΙΤΛΟΙ

2025: Διδάκτωρ Ιατρικής Σχολής Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών
2025: Πρόγραμμα μεταπτυχιακών σπουδών «Καρδιακή Ανεπάρκεια - Καρδιο-ογκολογία - Καρδιαγγειακή Αποκατάσταση» - Πανεπιστήμιο Θεσσαλίας
2024: Εξειδίκευση στην καρδιο-ογκολογία- Specialty training, Cardio-Oncology Center of Excellence, Amyloid Center of Excellence, Washington University, St . Louis, Missouri, USA
2024: Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management- ASNC
2024: Level I Competence in Cardiovascular Magnetic Resonance - SOCIATY OF CARDIOVASCULAR MAGNETIC RESONANCE SCMR
2023: Εξειδίκευση στις νεότερες υπερηχοκαρδιογραφικές τεχνικές – Γ.Ν.Α. Ιπποκράτειο, Αθήνα
2023: Health After Cancer: Cancer Survivorship for Primary Care- Stanford School of Medicine-Stanford University
2023: Cancer Survivorship: Optimizing Care and Outcomes- Harvard Medical School - Harvard University
2020: Τίτλος Ιατρικής Ειδικότητας Καρδιολογίας
2017: Hammersmith Hospital Echocardiography Department - Imperial College, London –United Kingdom (εκπαίδευση στον τομέα της ηχωκαρδιογραφίας)
2009: Πτυχίο Ιατρικής (MD in Medicine and Surgery , Universita’ degli studi dell’Aquila (βαθμός: 102/110) με Ευρωπαϊκή αναγνώρηση (“ESAME DI STATO” - sess. April / July 2009, βαθμός: 268.75 / 270)

ΠΡΟΫΠΗΡΕΣΙΑ

2023 – σήμερα: METROPOLITAN GENERAL- Ε’Καρδιολογική κλινική (Επιμελήτρια, Ειδικός καρδιολόγος)
2023 – σήμερα: Μονάδα Καρδιο-ογκολογίας- Α’ Πανεπιστημιακή Καρδιολογική Κλινική, Γ.Ν. Α. Ιπποκράτειο - Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών - Επιστ. Συνεργάτης - Υπεύθυνη τμήματος
2017: Hammersmith Hospital Echocardiography Department - Imperial College, London –United Kingdom (εκπαίδευση στον τομέα της ηχωκαρδιογραφίας)
2016 – 2022: A’ Καρδιολογική κλινική - Γ.Ν.Α Ο Ευαγγελισμός (ειδικευόμενη ιατρός)
2014 – 2016: Καρδιολογική κλινική Γενικού Παναρκαδικού Νοσοκομείου -Τρίπολη (ειδικευόμενη ιατρός)
2013-2023: Μονάδα Υπέρτασης, Α’ Πανεπιστημιακή Καρδιολογική Κλινική Γ.Ν. Α. Ιπποκράτειο - Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (Επιστημονικός Συνεργάτης)
2012 –2013: A’ Παθολογική κλινική Γ.Ν. Καλαμάτας (ειδικευόμενη ιατρός)
2010 – 2011: Περιφερειακο Ιατρειο, Κέντρο Υγείας Λογγα- Κ.Υ.Μεσσήνης (Ιατρός Υπερεσίας Υπαίθρου)

ΜΕΛΟΣ ΕΤΑΙΡΕΙΩΝ, ΣΥΝΤΑΚΤΙΚΗΣ ΕΠΙΤΡΟΠΗΣ ΠΕΡΙΟΔΙΚΩΝ

Ιατρικός Σύλλογος Αθηνών
Ιατρικός Σύλλογος Πειραιά
Ελληνική Καρδιολογική εταιρία, EKE
FESC, ESC Cardio-Oncology Fellow
Υπερηχοκαρδιογραφία στην Κλινική Πράξη (K. Αγγέλη, Δ. Τούσουλης)

ΤΙΜΗΤΙΚΕΣ ΔΙΑΚΡΙΣΕΙΣ

ΔΗΜΟΣΙΕΥΣΕΙΣ

«Η ΠΕΡΙΚΑΡΔΙΑΚΗ ΝΟΣΟΣ ΣΤΟΥΣ ΟΓΚΟΛΟΓΙΚΟΥΣ ΑΣΘΕΝΕΙΣ» ΚΑΡΔΙΑ ΚΑΙ ΑΓΓΕΙΑ, 2025 ΤΕΥΧ.4, 24-35
“The Effect of Renal Denervation on Capillary Density in Patients With Uncontrolled Hypertension” Microcirculation. 2025 Jul;32(5):e70015. doi: 10.1111/micc.70015. PMID: 40544439; PMCID: PMC12182759.
«ΚΑΡΔΙΑΓΓΕΙΑΚΕΣ ΕΠΙΠΤΩΣΕΙΣ ΤΗΣ ΑΚΤΙΝΟΘΕΡΑΠΕΙΑΣ: ΤΙ ΠΡΕΠΕΙ ΝΑ ΓΝΩΡΙΖΕΙ Ο ΚΑΡΔΙΟΛΟΓΟΣ.» ΚΑΡΔΙΑ ΚΑΙ ΑΓΓΕΙΑ, 2024 ΤΕΥΧ.3, 16-28
“EFFECTS OF TRANSCATHETER CLOSURE OF PATENT FORAMEN OVALE ON LEFT ATRIAL FUNCTION” EuroPCR 2024
¨MULTIMODALITY IMAGING APPROACH IN A CASE OF VASCULAR TOXICITY CAUSED BY CABOZANTINIB¨ Radiology Case Reports, Vol.19, Issue 1, January 2024, pg 62-65
«ΑΝΕΞΑΡΤΗΤΟΙ ΠΡΟΓΝΩΣΤΙΚΟΙ ΔΕΙΚΤΕΣ ΚΑΡΔΙΑΓΓΕΙΑΚΩΝ ΣΥΜΒΑΜΑΤΩΝ ΣΕ ΑΣΘΕΝΕΙΣ ΜΕ ΚΑΡΚΙΝΟ» 44th International Congress of Cardiology (Athens,2023)
«ΜΕΤΑΒΟΛΕΣ ΣΤΗ ΛΕΙΤΟΥΡΓΙΚΟΤΗΤΑ ΤΟΥ ΑΡΙΣΤΕΡΟΥ ΚΟΛΠΟΥ ΜΕΤΑ ΑΠΟ ΔΙΑΚΑΘΕΤΗΡΙΑΚΗ ΣΥΓΚΛΕΙΣΗ ΒΑΤΟΥ ΩΟΕΙΔΟΥΣ ΤΡΗΜΑΤΟΣ» 44th International Congress of Cardiology (Athens,2023)
«ΠΡΟΫΠΕΡΤΑΣΗ. ΠΡΟΓΝΩΣΤΙΚΗ ΣΗΜΑΣΙΑ ΚΑΙ ΑΝΤΙΜΕΤΩΠΙΣΗ» Καρδιά και αγγεία, Μάρτιος- Απρίλιος 2018, τευχ.2, 97-101
« ΣΤΈΝΩΣΗ ΙΣΘΜΟΎ ΤΗΣ ΑΟΡΤΉΣ: ΤΡΈΧΟΥΣΑ ΘΕΏΡΗΣΗ» Καρδιά και αγγεία,2016 τευχ.2, 89-97
“EFFECTS OF SARS-COV-2 INFECTION ON THE CARDIORESPIRATORY PERFORMANCE BY HYPERTENSION STATUS” Journal of Hypertension, Volume 41, Supplement 3 (2023) DOI:https://doi.org/10.1097/01.hjh.0000940808.15711.18
“CARDIOPULMONARY STATUS AND RIGHT VENTRICLE FUNCTIONALITY IN HYPERTENSIVE PATIENTS HOSPITALIZED OR NOT FOR SARS-COV-2 INFECTION” Journal of Hypertension, Volume 41, Supplement 3 (2023), DOI: https://doi.org/10.1097/01.hjh.0000940804.66185.69
“EFFECTS OF IVABRADINE ON SYMPATHETIC OVERDRIVE AND ARTERIAL STIFFENING IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME: A 6 MONTH FOLLOW-UP STUDY” JACC March 20, 2018Volume 71, Issue 11 (2018)
BLOOD PRESSURE RESPONSE TO CATHETER-BASED RENAL SYMPATHETIC DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION: DATA FROM A NATIONAL MULTICENTER 1-YEAR- FOLLOW-UP STUDY” J Am Coll Cardiol. 2017 Mar, 69 (11_Supplement) 1725 (2017)
“URIC ACID LEVELS PREDICT CORONARY ARTERY DISEASE BUT NOT STROKE IN ESSENTIAL HYPERTENSION: DATA FROM A GREEK 8-YEAR-FOLLOW-UP STUDY” Cirulation- November 11, 2016 ,Vol 134, Issue suppl_1(2016)
“EFFECTS OF MULTIELECTRODE RENAL DENERVATION ON SYMPATHETIC NERVE ACTIVITY AND INSULIN RESISTANCE IN METABOLIC SYNDROME” J Am Coll Cardiol. 2016 Nov, 68 (18_Supplement) (2016)
“CARDIOVASCULAR PROGNOSIS OF COMBINED PATTERNS OF RESISTANT HYPERTENSION AND SMOKING STATUS: A 3.6 YEAR FOLLOW-UP STUDY” J Am Coll Cardiol. 2015 Mar, 65 (10_Supplement) (2015)
“PREDICTORS AND CARDIOVASCULAR PROGNOSIS OF INCIDENT AND PERSISTENT RESISTANT HYPERTENSION: A 4-YEAR FOLLOW-UP STUDY”- Journal of American College of Cardiology's(2014)
“EVENING VERSUS MORNING DOSING OF ANTIHYPERTENSIVE DRUGS IN HYPERTENSIVE PATIENTS WITH SLEEP APNEA: A CROSS-OVER STUDY”- Journal of American College Of Cardiology's(2014)
“COMBINED PATTERNS OF SMOKING AND EXCESS WEIGHT FOR PREDICTION OF CARDIOVASCULAR DISEASE IN HYPERTENSIVE PATIENTS: A 4-YEAR FOLLOW-UP STUDY”- Journal of American College of Cardiology's(2014)
“COMPARISON OF THE PULSE WAVE VELOCITY WITH LEFT VENTRICULAR HYPERTROPHY FOR PREDICTING CORONARY ARTERY DISEASE IN PATIENTS WITH ESSENTIAL HYPERTENSION: DATA FROM 6- YEAR FOLLOW-UP STUDY” - 35th International Congress of Cardiology (Athens,2014)
“ASSESSMENT OF CARDIOVASCULAR MORTALITY DEPENDING ON THE NATURAL HISTORY OF RESISTANT HYPERTENSION: ANALYSIS 4-YEAR FOLLOW-UP STUDY USING TIME-DEPENDENT VARIABLES” - 35th International Congress of Cardiology (Athens,2014)
“POSITIVE EFFECT OF IVABRADINE ON SYMPATHETIC OVERACTIVITY AND ARTERIAL STIFFNESS IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME” - 35th International Congress of Cardiology (Athens,2014)
“PROGNOSTIC FACTORS EMERGING ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS. THE DOMINANT ROLE OF THE LEFT ATRIUM” - 35th International Congress of Cardiology (Athens,2014)
“THE METABOLIC SYNDROME IS ASSOCIATED WITH A HIGH LEVEL OF STIMULATION OF THE SYMPATHETIC NERVOUS SYSTEM AND INCREASED ARTERIAL STIFFNESS IN PATIENTS WITH RESISTANT HYPERTENSION”- 35th International Congress of Cardiology (Athens,2014)
“RELATIONSHIP BETWEEN RENAL HEMODYNAMICS AND HEMODYNAMICS OF THE HEART AND AORTA IN EARLY ESSENTIAL HYPERTENSION”- 35th International Congress of Cardiology (Athens,2014)
“METABOLIC SYNDROME AND DIABETES MELLITUS INDEPENDENTLY PREDICT ADVERSE EVENTS IN ESSENTIAL HYPERTENSIVE SUBJECTS”- Joint Meeting of the ESH and ISH (Athens, 2014)
“WAIST CIRCUMFERENCE VERSUS OTHER OBESITY PARAMETERS AS DETERMINANTS OF CORONARY ARTERY DISEASE IN ESSENTIAL HYPERTENSION” - Joint Meeting of the ESH and ISH (Athens, 2014)
“INCIDENT AND PERSISTENT RESISTANT HYPERTENSION DURING LONG TERM FOLLOW-UP IS ACCOMPANIED BY LACK OF REGRESSION OF LEFT VENTRICULAR HYPERTROPHY IN ESSENTIAL HYPERTENSIVES” – Joint Meeting of the ESH and ISH (Athens, 2014)
“RELATIONSHIPS OF METABOLIC SYNDROME AND DIABETES MELLITUS WITH INCIDENT AND PERSISTENT RESISTANT HYPERTENSION IN ESSENTIAL HYPERTENSIVE SUBJECTS”- Joint Meeting of the ESH and ISH (Athens, 2014)
“PARALLEL DETERIORATION OF ALBUMINURIA AND OXYGEN SATURATION IN ESSENTIAL HYPERTENSION: INTEGRATING VASCULAR DYSFUNCTION”- Joint Meeting of the ESH and ISH (Athens, 2014)
“CARDIOVASCULAR MORBIDITY ACCORDING TO THE PHYSICAL COURSE OF RESISTANT HYPERTENSION: A TIME UPDATED ANALYSIS OF A 4 YEAR PROSPECTIVE STUDY”- Joint Meeting of the ESH and ISH (Athens, 2014)
“EFFECTS OF MULTI-ELECTRODE CATHETER-BASED RENAL SYMPATHETIC DENERVATION ON CARDIAC DAMAGE AND NEUROHORMONAL ACTIVATION IN SEVERE DRUG RESISTANT HYPERTENSION”- Joint Meeting of the ESH and ISH (Athens, 2014)
“EVALUATION OF WHITE COAT HYPERTENSION USING AUTOMATED OFFICE BLOOD PRESSURE VERSUS OFFICE BLOOD PRESSURE MEASUREMENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE”- Joint Meeting of the ESH and ISH (Athens, 2014)
“RELIABILITY OF AUTOMATED OFFICE BLOOD PRESSURE IN THE ASSESSMENT OF MORNING HYPERTENSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE”- Joint Meeting of the ESH and ISH (Athens, 2014)
“RELATIONSHIPS BETWEEN RENAL HAEMODYNAMICS WITH CARDIAC AND AORTIC HAEMODYNAMICS IN THE EARLY STAGES OF ESSENTIAL HYPERTENSION”- Joint Meeting of the ESH and ISH (Athens, 2014)
“COMPARISON OF CARDIOVASCULAR RISK OF RESISTANT HYPERTENSION AGAINST THAT OF SMOKING: A 3.6 YEAR FOLLOW-UP STUDY”- Joint Meeting of the ESH and ISH (Athens, 2014)
“LACK OF REGRESSION OF LEFT VENTRICULAR HYPERTROPHY IS ACCOMPANIED BY ADVERSE PROGNOSIS IN ESSENTIAL HYPERTENSIVES”- Joint Meeting of the ESH and ISH (Athens, 2014)
“EVALUATION OF DIURETIC’S EFFICACY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERTENSION ASSESSED BY AMBULATORY BLOOD PRESSURE MEASUREMENTS”- Joint Meeting of the ESH and ISH (Athens, 2014)
“EVALUATION OF THE EVENING DOSAGE OF ANTIHYPERTENSIVE DRUG IN BLOOD PRESSURE CONTROL AND DIPPING STATUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE”- Joint Meeting of the ESH and ISH (Athens, 2014)
“STUDY OF ARTERIAL HYPERTENSION ON WOMEN IN RURAL POPULATION” - presented at the 3rd National Conference of Pre-Hospital Cardiology (2nd AWARD)
“DIRECT EFFECTS OF INTENSE PHYSICAL EXERCISE IN HEART RATE AND BLOOD PRESSURE” – 7th Panhellenic Conference Cardiometabolic Risk Factors (Kalamata,2014)
«LATE MANIFESTATION OF NEUTROPENIC FEVER AS CONSEQUENCE OF ANTITHYROID DRUG SOMMINISTRATION" presented at the 5th Congress of Health of Messinia (2nd AWARD)
“MANAGEMENT OF ARTERIAL HYPERTENSION ON POST-MENOPAUSAL WOMEN, IMPACT OF LIVING IN CONSOLIDATION AND TREATMENT OF ARTERIAL HYPERTENSION” presented at the 13th National Congress of Hypertension (Greece)
“BROWN-SEQUARD SYNDROME: PRESENTATION AND FOLLOW UP OF A CASE REPORT” presented at the 1st National Congress of Greek College of General Practitioners (1st AWARD)
“ADDITIONAL/ALTERNATE TREATMENT SUBSEQUENT TO REFRACTIVE SURGERY TECHNIQUES UNDER TOPOGRAPHICAL GUIDANCE” (i.e. “Ritrattamenti Dopo Interventi Di Chirurgia Rifrattiva Con Tecniche A Guida Topografica”) – THESIS
“LOW BACK PAIN AS THE FIRST SYMPTOM OF ENDOKARDITIS” presented at the18th National Congress of Internal Medicine
“TREATMENT OF VRE ENDOCARDITIS WITH DAPTOMYCIN AND MANIFESTATION OF VERTIGO”